Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2018
ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients
M Hutchings, M Ladetto, C Buske, et al.
Leukemia
|
April 17, 2012
Impact of serum storage conditions on microRNA stability
S Grasedieck, N Schöler, M Bommer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
F d'Amore, M Federico, L de Leval, et al.
Critical Reviews in Oncology/Hematology
|
October 7, 2005
Towards a pathogenesis-oriented therapy of acute myeloid leukemia
W Hiddemann, K Spiekermann, C Buske, et al.
Leukemia
|
March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma
G Hess, U Keller, C W Scholz, et al.
Leukemia
|
November 10, 2012
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
L Chen, A J Deshpande, D Banka, et al.
Leukemia
|
January 23, 2009
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia
S Thoene, V P S Rawat, B Heilmeier, et al.
Leukemia
|
July 13, 2007
AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia
F Schneider, S K Bohlander, S Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
W Jurczak, P L Zinzani, G Gaidano, et al.
Leukemia
|
November 9, 2011
CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12
M A Mulaw, A Krause, A J Krause, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2018
ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients
M Hutchings, M Ladetto, C Buske, et al.
Leukemia
|
April 17, 2012
Impact of serum storage conditions on microRNA stability
S Grasedieck, N Schöler, M Bommer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
F d'Amore, M Federico, L de Leval, et al.
Critical Reviews in Oncology/Hematology
|
October 7, 2005
Towards a pathogenesis-oriented therapy of acute myeloid leukemia
W Hiddemann, K Spiekermann, C Buske, et al.
Leukemia
|
March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma
G Hess, U Keller, C W Scholz, et al.
Leukemia
|
November 10, 2012
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
L Chen, A J Deshpande, D Banka, et al.
Leukemia
|
January 23, 2009
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia
S Thoene, V P S Rawat, B Heilmeier, et al.
Leukemia
|
July 13, 2007
AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia
F Schneider, S K Bohlander, S Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
W Jurczak, P L Zinzani, G Gaidano, et al.
Leukemia
|
November 9, 2011
CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12
M A Mulaw, A Krause, A J Krause, et al.
Page
of 10